Human, economic, and social impact of lysosomal storage diseases
LSDs impose a substantial economic and social burden on patients and their families, with high healthcare costs and significant productivity losses. The study underscores the need for comprehensive support strategies addressing both economic and social challenges faced by affected families. Future research should explore country-specific economic impacts and develop policies to mitigate the financial strain on these families.
Authors
- Eduardo Brignani
- Guillem Pintos‐Morell (ORCID: https://orcid.org/0000-0002-9347-2386)
- Antonio González‐Meneses (ORCID: https://orcid.org/0000-0003-1774-6266)
- Montserrat Morales (ORCID: https://orcid.org/0000-0003-0064-9718)
- José Luís Poveda (ORCID: https://orcid.org/0000-0003-1800-6198)
- Jordi Cruz
- Imma Vilalta
- Gabriel Fernando Ballester-Lozano
- Héctor David de Paz
- María José de Castro-López
Institutions
- Hospital Sant Joan de Déu Barcelona (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Manchester University NHS Foundation Trust (GB)
- Ministry of Health (ES)
- Hospital Universitario 12 De Octubre (ES)
- Vall d'Hebron Institut de Recerca (ES)
- Hospital d'Igualada (ES)
- Federación Española de Enfermedades Raras (ES)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Hospital Universitario Virgen del Rocío (ES)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1186/s13023-025-04053-z
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00